Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2023 Earnings Ca

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Conference Call.

Related Keywords

Janet Hammond , Jonae Barnes , Arantxa Horga , John Vavricka , John Miller , Jean Pierre Sommadossi , Andrea Corcoran , Maxwell Skor , Deric Joseph , Morgan Stanley , Health Photo , Public Health Emergency , Nasdaq , National Cancer Institute On Unsplash , Exchange Commission , Atea Pharmaceuticals Inc , Jp Morgan , World Health Organization , Pfizer , Corporate Communications At Atea Pharmaceuticals , Atea Pharmaceuticals , Call Transcript May , Atea Pharmaceutical First Quarter , Business Update Conference , Senior Vice President , Investor Relations , Corporate Communications , Atea Pharmaceutical , Chief Executive Officer , Chief Development Officer , Chief Medical Officer , Financial Officer , Executive Vice President , Chief Commercial Officer , Forward Looking Statements , Pierre Sommadossi , National Cancer Institute , Health Emergency , Interest Yielding Checking Accounts , Consulting Stocks ,